TNXP icon

Tonix Pharmaceuticals

hedge funds and large institutions have $1.15M invested in Tonix Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$653K
OAM
2
Oxford Asset Management
United Kingdom
$114K
Renaissance Technologies
3
Renaissance Technologies
New York
$111K -$150K
AFM
4
Anson Funds Management
Texas
$68K
BFM
5
Boothbay Fund Management
New York
$44K
Bank of New York Mellon
6
Bank of New York Mellon
New York
$38K
Geode Capital Management
7
Geode Capital Management
Massachusetts
$36K -$22K
CH
8
CVI Holdings
Delaware
$36K
Citigroup
9
Citigroup
New York
$34K
Macquarie Group
10
Macquarie Group
Australia
$6K
Morgan Stanley
11
Morgan Stanley
New York
$2K -$1K
BlackRock
12
BlackRock
New York
$1K -$3K
Wells Fargo
13
Wells Fargo
California
$1K -$2K
Bank of America
14
Bank of America
North Carolina
$1K -$3K
UBS Group
15
UBS Group
Switzerland
-$2K
Northern Trust
16
Northern Trust
Illinois
-$7K
Vanguard Group
17
Vanguard Group
Pennsylvania
-$119K
ARTA
18
A.R.T. Advisors
New York
-$29K
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
-$34K
SG Americas Securities
20
SG Americas Securities
New York
-$8K
PAM
21
Panagora Asset Management
Massachusetts
-$4K
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
-$4K
LTFS
23
Ladenburg Thalmann Financial Services
Florida
-$1K
Citadel Advisors
24
Citadel Advisors
Florida
-$22K
TSS
25
Two Sigma Securities
New York
-$25K